Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TASIGNA for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where TASIGNA was used for Neoplasm malignant.

Most Reported Side Effects for TASIGNA

Side Effect Reports % Deaths Hosp.
Death 76 9.8% 76 6
Fatigue 67 8.7% 3 6
Rash 53 6.9% 0 5
Nausea 42 5.4% 2 7
Dyspnoea 37 4.8% 6 15
Headache 31 4.0% 0 6
Chronic myeloid leukaemia 30 3.9% 16 8
Malignant neoplasm progression 28 3.6% 17 5
Anaemia 27 3.5% 6 9
Electrocardiogram qt prolonged 27 3.5% 0 4
Pruritus 27 3.5% 0 3
Diarrhoea 26 3.4% 0 3
Myocardial infarction 25 3.2% 5 13
Chest pain 23 3.0% 1 13
Alopecia 22 2.9% 0 0

Other Indications for TASIGNA

Chronic myeloid leukaemia (562) Off label use (21) Acute lymphocytic leukaemia (10) Leukaemia (9) Gastrointestinal stromal tumour (8) Product used for unknown indication (6) Acute myeloid leukaemia (5)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

TASIGNA Full Profile All Neoplasm malignant Drugs TASIGNA Demographics TASIGNA Timeline